Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer
Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer
This study is being done to find the effect of Dibenzyl Trisulphide (active ingredient in
 Guinea Hen Weed in combination in patients with stage four cancer of the breast, prostate,
 cervix and colon.
There have been many claims of the value of Guinea Hen weed in the treatment of different
 cancers. The preparation is readily available and used locally. The team proposes to validate
 the studies done on cancer cell lines by conducting a clinical trial to determine the
 clinical benefit in advanced and metastatic cancers.
Inclusion Criteria:

 -  Age: Greater than 12 years.

 -  Documented histologic evidence of cancer

 -  Staged as stage IV

 -  World Health Organization (WHO) Performance Status of between 0 and 2

 -  Radiological confirmation of metastases with bone scan or X ray, CT and/or MRI scan
 Exclusion Criteria

 -  Cancer stages less than stage 4

 -  Pregnant women

 -  Children 0 - 12 years